Review: ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia

被引:0
|
作者
Lavin, LF [1 ]
Khanna, KK
机构
[1] Queensland Inst Med Res, Queensland Canc Fund, Res Unit, Brisbane, Qld 4029, Australia
[2] Univ Queensland, PO Royal Brisbane Hosp, Dept Surg, Brisbane, Qld 4029, Australia
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To provide an update on the product of the ATM gene mutated in the human genetic disorder ataxia-telangiectasia (A-T). Summary: The product of the ATM gene mutated in the human genetic disorder A-T is a 350 kDa protein that plays a central role in the regulation of a number of cellular processes. It is a member of the phosphatidylinositol 3-kinase superfamily, but is more likely a protein kinase similar to another member of that family, i.e. DNA-dependent protein kinase (DNA-PK). A-T cells and fibroblasts derived from the atm(-/-) mouse are hypersensitive to ionizing radiation and defective in cell cycle checkpoint control. At present the nature of the lesion in damaged DNA recognized by ATM remains uncertain, but it is evident that a small number of residual strand breaks remain unrepaired in A-T cells, which may well account for the radiosensitivity. On the other hand, considerable progress has been achieved in delineating the role of ATM in cell cycle checkpoint control. Defects are observed at all cell cycle checkpoints in R-T cells post-irradiation. At the G(1)/S interface ATM has been shown to play a central role in radiation-induced activation of the tumour suppressor gene product p53. ATM binds to p53 in a complex fashion and activates the molecule in response to breaks in DNA by phosphorylating it at serine 15 close to the N-terminus and by controlling other phosphorylation and dephosphorylation changes on the molecule. This in turn leads to the induction of p21/WAF1 and other p53 effector proteins before inhibition of cyclin-dependent kinase activity and GI arrest. Emerging evidence supports a direct role for ATM at other cell cycle checkpoints. Other proteins interacting with ATM include c-Abl a protein tyrosine kinase, beta-adaptin an endosomal protein and p21 a downstream effector of p53. The significance of these interactions is currently being investigated. ATM also plays an important role in the regulation and surveillance of meiotic progression. The localization of ATM to both the nucleus and other subcellular organelles implicates this molecule in a myriad of cellular processes. Conclusion: ATM is involved in DNA damage recognition and cell cycle control in response to ionizing radiation damage. There is evidence that ATM may also have a more general signalling role.
引用
收藏
页码:1201 / 1214
页数:14
相关论文
共 50 条
  • [21] Role of the ataxia-telangiectasia gene (ATM) in breast cancer
    Lavin, M
    BRITISH MEDICAL JOURNAL, 1998, 317 (7157): : 486 - 487
  • [22] Comments on the paper: The ATM gene and the radiobiology of ataxia-telangiectasia
    Foray, N
    Badie, C
    Arlett, CF
    Malaise, EP
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1997, 71 (04) : 449 - 450
  • [23] Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms
    Dianne Watters
    Kum Kum Khanna
    Heather Beamish
    Geoffrey Birrell
    Kevin Spring
    Padmini Kedar
    Magtouf Gatei
    Deborah Stenzel
    Karen Hobson
    Sergei Kozlov
    Ning Zhang
    Aine Farrell
    Jonathan Ramsay
    Richard Gatti
    Martin Lavin
    Oncogene, 1997, 14 : 1911 - 1921
  • [24] Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene)
    Asadollahi, Reza
    Britschgi, Christian
    Joset, Pascal
    Oneda, Beatrice
    Schindler, Detlev
    Meier, Urs R.
    Rauch, Anita
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (10):
  • [25] Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms
    Watters, D
    Khanna, KK
    Beamish, H
    Birrell, G
    Spring, K
    Kedar, P
    Gatei, M
    Stenzel, D
    Hobson, K
    Kozlov, S
    Zhang, N
    Farrell, A
    Ramsay, J
    Gatti, R
    Lavin, M
    ONCOGENE, 1997, 14 (16) : 1911 - 1921
  • [26] Ataxia-Telangiectasia Mutated (ATM) Protein Signaling Participates in Development of Pulmonary Arterial Hypertension in Rats
    Hu, Fan
    Liu, Caijun
    Liu, Hanmin
    Xie, Liang
    Yu, Li
    MEDICAL SCIENCE MONITOR, 2017, 23 : 4391 - 4400
  • [27] Agreement of cardiovascular risk in ataxia-telangiectasia mutated heterozygotes and their children with Ataxia-telangiectasia
    Neves Barreto, Talita Lemos
    De Almeida Kotchetkoff, Elaine Cristina
    Aranda Lago, Carolina Sanchez
    Saccardo Sarni, Roseli Oselka
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (06): : 209 - 213
  • [28] Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review
    Jerzak, K. J.
    Mancuso, T.
    Eisen, A.
    CURRENT ONCOLOGY, 2018, 25 (02) : E176 - E180
  • [29] Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM
    Hickson, I
    Yan, Z
    Richardson, CJ
    Green, SJ
    Martin, NMB
    Orr, AI
    Reaper, PM
    Jackson, SP
    Curtin, NJ
    Smith, GCM
    CANCER RESEARCH, 2004, 64 (24) : 9152 - 9159
  • [30] Ataxia-telangiectasia syndrome
    Fortuna, Joana
    Rodrigues, Ana Luisa
    Pires, Paula
    PEDIATRICS AND NEONATOLOGY, 2022, 63 (05): : 551 - 552